Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

United Health Products (UEEC) Research & Development (2018 - 2025)

United Health Products' Research & Development history spans 8 years, with the latest figure at $47299.0 for Q4 2025.

  • Quarterly results put Research & Development at $47299.0 for Q4 2025, down 56.52% from a year ago — trailing twelve months through Dec 2025 was $269867.0 (down 24.18% YoY), and the annual figure for FY2025 was $269867.0, down 24.18%.
  • Research & Development for Q4 2025 was $47299.0 at United Health Products, up from $25334.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $218676.0 in Q1 2023 to a low of $19757.0 in Q3 2021.
  • The 5-year median for Research & Development is $97874.5 (2021), against an average of $104331.6.
  • The sharpest move saw Research & Development tumbled 67.09% in 2021, then skyrocketed 988.11% in 2022.
  • Year by year, Research & Development stood at $90636.0 in 2021, then surged by 131.28% to $209620.0 in 2022, then fell by 26.89% to $153260.0 in 2023, then dropped by 29.02% to $108779.0 in 2024, then tumbled by 56.52% to $47299.0 in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $47299.0, $25334.0, and $80983.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.